PREVALENSI PASIEN COVID-19 DENGAN PENYAKIT KOMORBID DI SEMEN PADANG HOSPITAL TAHUN 2020

Ade Teti Vani; Raihana Rustam; Rika Amran; Nadia Dewi; Febrina Ulfa

Authors

Ade Teti Vani Medical Faculty Baiturrahmah University
Raihana Rustam Medical Faculty Baiturrahmah University
Rika Amran Medical Faculty Baiturrahmah University
Nadia Dewi
Febrina Ulfa Medical Faculty Baiturrahmah University

Keywords:

COVID 19, Comorbid Disease, Hypertension, Immune system

Abstract

The severity of patients confirmed positive for COVID-19 can be influenced by comorbid diseases in patients. This comorbid disease can cause a decrease in the patient's immune system than patients who do not have a comorbid disease. To determine the prevalence of COVID-19 patients with comorbid diseases at Semen Padang Hospital in 2020. The most gender was male, namely 55 people (56.7%), the average age was 54 years, with a median value of 55 and a mode value of 55, the highest degree of COVID-19 was moderate, namely 53 people (54.6% ), and the most comorbid hypertension was 49 people (50.5%). Most of the sexes are male, the average age is 54 years, the highest degree of COVID-19 is moderate, and the most comorbid is hypertension.

Downloads

Download data is not yet available.

Author Biographies

Raihana Rustam, Medical Faculty Baiturrahmah University

Ophtalmology department

Rika Amran, Medical Faculty Baiturrahmah University

Public Health Department

Nadia Dewi

Anatomy Department

Febrina Ulfa, Medical Faculty Baiturrahmah University

student of medical faculty baiturrahmah university

References

A. F. Rahman and S. K. Kartinah, “Gambaran Kondisi Lansia Penderita Covid 19 dengan Penyakit Diabetes Melitus dan Hipertensi: Literature Review,” pp. 1–19, 2021.

F. Li, “Structure, Function, and Evolution of Coronavirus Spike Proteins,” Annu. Rev. Virol., vol. 3, pp. 237–261, 2016, doi: 10.1146/annurev-virology-110615-042301.

P. D. P. Indonesia and (PDPI), Pneumonia COVID-19 Diagnosis Dan Penatalaksanaan Di Indonesia, no. 5. Jakarta, 2020.

S. Hamid, M. Y. Mir, and G. K. Rohela, “Novel Coronavirus Disease (COVID-19): A Pandemic (Epidemiology, Pathogenesis And Potential Therapeutics),” New Microbes New Infect., vol. 35, p. 100679, 2020, doi: 10.1016/j.nmni.2020.100679.

World Health Organization, “WHO Coronavirus (COVID-19) Dashboard,” 2021. .

World Health Organization, “WHO Global Indonesia (2021),” 2021. .

Sumbarprov, “Info Covid-19 Sumbar,” 2021. .

Satuan Tugas Penanganan COVID-19, “PPKM Mikro, Upaya Spesifik Menekan Laju Pandemi,” 2021. .

Satuan Tugas Penanganan COVID-19, “Satgas Covid-19 Sampaikan 3 Poin Penting Dari Pembelajaran Selama Masa PPKM,” 2021. .

S. PAPDI, “Kesiapan Kementrian Kesehatan RI Dalam Menghadapi Outbreak Novel Coronavirus,” Kementrian Kesehat. RI, pp. 1–26, 2020.

julvainda eka P.u, W. Fauzia, and M. Jamaluddin, “Edukasi Penerapan Protokol Kesehatan Sebagai Upaya Pencegahan Penyebaran COVID-19 Pada Penderita Komorbid,” Ilm. Media Husada, vol. 10, pp. 34–41, 2021, doi: https://doi.org/10.33475/jikmh.diisiredaksi.

A. Susilo et al., “Coronavirus Disease 2019: Tinjauan Literatur Terkini,” J. Penyakit Dalam Indones., vol. 7, no. 1, p. 45, 2020, doi: 10.7454/jpdi.v7i1.415.

C. Huang et al., “Clinical Features Of Patients Infected With 2019 Novel Coronavirus In Wuhan, China,” Lancet, vol. 395, no. 10223, pp. 497–506, 2020, doi: 10.1016/S0140-6736(20)30183-5.

D. Wang et al., “Clinical Characteristics Of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia In Wuhan, China,” JAMA - J. Am. Med. Assoc., vol. 323, no. 11, pp. 1061–1069, 2020, doi: 10.1001/jama.2020.1585.

R. M. A. Satria, R. V. Tutupoho, and D. Chalidyanto, “Analisis Faktor Risiko Kematian dengan Penyakit Komorbid Covid-19,” J. Keperawatan Silampari, vol. 4, no. 1, pp. 48–55, 2020, doi: 10.31539/jks.v4i1.1587.

M. L. Ndera, N. Supriyatni, and A. Rahayu, “Faktor Komorbid Terhadap Covid-19 di Puskesmas Kota Tahun 2020,” J. Biosaintek, vol. 3, no. 1, pp. 1–9, 2021.

A. Shobri and R. Herviastuti, “Laporan Kasus : Kejadian Hipoglikemia Pada Pasien Covid-19 Dengan Komorbid Diabetes Melitus Selama Menjalani Isolasi Mandiri,” Pros. Semin. Nas. Keperawatan Univ. Muhammadiyah Surakarta, pp. 19–27, 2021.

M. R. Sulaiman and S. P. Anggraeni, “Lelaki Atau Perempuan, Siapa Yang Lebih Rentan Terinfeksi Virus Corona,” Suara, 2020. .

D. Destylya, “Karakteristik Pasien Covid-19 Di Rumah Sakit Umum Pusat Haji Adam Malik Medan Sumatera Utara,” Sumatera Utara, 2021.

S. Liu et al., “Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: A retrospective multicentre cohort study,” BMC Infect. Dis., vol. 20, no. 1, pp. 1–34, 2020, doi: 10.1186/s12879-020-05314-x.

S. B. Ahmed and S. M. Dumanski, “Sex, gender and COVID-19: a call to action,” Can. J. Public Heal., vol. 111, no. 6, pp. 980–983, 2020, doi: 10.17269/s41997-020-00417-z.

P. Qiu et al., “Clinical Characteristics, Laboratory Outcome Characteristics, Comorbidities, And Complications Of Related COVID-19 Deceased: A Systematic Review And Meta-Analysis,” Aging Clin. Exp. Res., vol. 32, no. 9, pp. 1869–1878, 2020, doi: 10.1007/s40520-020-01664-3.

W. Y. Kangdra, “Karakteristik Klinis Dan Faktor Komorbid Pada Pasien Dalam Pengawasan (PDP) Coronavirus Disease 2019 (Covid-19) Di RS Mitra Medika Amplas,” Sumatera Utara, 2021.

X. Liang, “Infection COVID-19,” Elsevier, vol. 81, pp. 44–47, 2020.

X. qing Liu et al., “Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China,” Acta Pharmacol. Sin., vol. 43, no. 1, pp. 64–75, 2022, doi: 10.1038/s41401-021-00627-2.

M. Ekaputri, D. Efliani, and S. Witri, “Gambaran Karakteristik Pasien Covid 19 di Rumah Sakit Ibnu sina Pekan Baru,” Amanah Kesehat., vol. 3, no. 2, p. 128, 2021.

J. T. Widjaja, L. Kwee, A. K. Giantara, H. A. Suabgiyo, C. Edwin, and R. L. Putri, “Karakteristik Pasien COVID-19 Rawat Inap di RS Immanuel Bandung, Indonesia,” J. Med. Heal., vol. 3, no. 2, pp. 164–175, 2021, doi: 10.28932/jmh.v3i2.3781.

H. Liu, S. Chen, M. Liu, H. Nie, and H. Lu, “Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: A systematic review and meta-analysis,” Aging Dis., vol. 11, no. 3, pp. 668–678, 2020, doi: 10.14336/AD.2020.0502.

W. Guan et al., “Clinical Characteristics of Coronavirus Disease 2019 in China,” N. Engl. J. Med., vol. 382, no. 18, pp. 1708–1720, 2020, doi: 10.1056/nejmoa2002032.

A. Gunawan, K. Prahasanti, and M. R. Utama, “Pengaruh Komorbid Hipertensi Terhadap Severitas Pasien Yang Terinfeksi Covid 19,” J. Implementa Husada, vol. 1, no. 2, pp. 136–151, 2020, doi: 10.30596/jih.v1i2.4972.

H. A. Willim, I. Ketaren, and A. I. Supit, “Dampak Coronavirus Disease 2019 terhadap Sistem Kardiovaskular,” e-Clinic, vol. 8, no. 2, pp. 237–245, 2020, doi: httpS://doi.org/10.35790/ecl.8.2.2020.30540.

L. A. D. Rahayu et al., “Hipertensi, Diabetes Melitus, Dan Obesitas Sebagai Faktor Komorbid Utama Terhadap Mortalitas Pasien COVID-19: Sebuah Studi Literatur,” Jimki J. Ilm. Mhs. Kedokt. Indones., vol. 9, no. 1, pp. 90–97, 2021.

I. Hikmawati and R. Setiyabudi, “Hipertensi Dan Diabetes Militus Sebagai Penyakit Penyerta Utama Covid-19 Di Indonesia,” Pros. Semin. Nas. Lppm Ump, vol. 0, no. 0, pp. 95–100, 2020.

I. Huang, M. A. Lim, and R. Pranata, “Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression: Diabetes and COVID-19,” Diabetes Metab. Syndr. Clin. Res. Rev., vol. 14, no. 4, pp. 395–403, 2020, doi: 10.1016/j.dsx.2020.04.018.

A. Abdi, M. Jalilian, P. A. Sarbarzeh, and Z. Vlaisavljevic, “Diabetes and COVID-19: A systematic review on the current evidences,” Diabetes Res. Clin. Pract., vol. 166, 2020, doi: 10.1016/j.diabres.2020.108347.

C. V. Ugwueze, B. C. Ezeokpo, B. I. Nnolim, E. A. Agim, N. C. Anikpo, and K. E. Onyekachi, “COVID-19 and Diabetes Mellitus: The Link and Clinical Implications,” Dubai Diabetes Endocrinol. J., vol. 26, no. 2, pp. 69–77, 2020, doi: 10.1159/000511354.

H. Surendra et al., “Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study,” Lancet Reg. Heal. - West. Pacific, vol. 9, pp. 1–19, 2021, doi: 10.1016/j.lanwpc.2021.100108.

N. Lestari, B. Ichsan, F. Kedokteran, U. M. Surakarta, K. N. Lestari, and M. P. H. Alamat, “Diabetes Melitus Sebagai Faktor Risiko Keparahan Dan Kematian Pasien Covid-19 : Meta-Analisis Diabetes Mellitus As a Risk Factor for Severity and Mortality of Covid-19 : a Meta-Analysis,” Biomedika, vol. 13, no. 1, pp. 83–94, 2020, doi: 10.23917/biomedika.v13i1.13544.